tenofovir has been researched along with Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eminler, AT; Hacibekiroglu, I; Koksal, AS; Parlak, E; Toka, B; Uslan, MI | 1 |
| Martin, L | 1 |
1 review(s) available for tenofovir and Melanoma
| Article | Year |
|---|---|
[What's new in dermatological treatments?].
Topics: Adenine; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials as Topic; Cyclosporine; Dermatofibrosarcoma; Dermatologic Agents; Dermatology; Drug Therapy, Combination; Etanercept; Follow-Up Studies; Gels; HIV Infections; Humans; Imatinib Mesylate; Immunoglobulin G; Immunosuppressive Agents; Ipilimumab; Melanoma; Neoplasm Staging; Organophosphonates; Piperazines; Psoriasis; Pyrimidines; Receptors, Tumor Necrosis Factor; Skin Diseases; Skin Neoplasms; Survival Analysis; Tenofovir; Treatment Outcome; Ustekinumab | 2010 |
1 other study(ies) available for tenofovir and Melanoma
| Article | Year |
|---|---|
HBV-related acute hepatitis due to immune checkpoint inhibitors in a patient with malignant melanoma.
Topics: Antibodies, Monoclonal; Antineoplastic Agents, Immunological; Antiviral Agents; Hepatitis B virus; Hepatitis, Viral, Human; Humans; Ipilimumab; Male; Melanoma; Middle Aged; Nivolumab; Tenofovir | 2017 |